A fully customized program to meet your healthcare goals

Weight loss is not our end goal here. It’s your empowerment to live a high-quality, sustainable lifestyle with immense health benefits.

In the nearly 7 years since the formation of Keto5, founder Dr. Michael Wool, a renowned university research physician with a background in HIV antiviral drug therapy, and Stanley Ho, an engineer, brought together a small group of physicians to explore weight control using exogenous ketone supplementation. 

A small clinical trial of 49 patients demonstrated weight loss averaging 10 pounds per month over eight weeks. During that time, it was noted that Keto5 patients with complicated medical diseases including diabetes, hypertension, asthma, and certain auto-immune diseases experienced additional improvement in their symptoms, laboratory measurement of inflammation, and reduction in standard of care prescription medications.  

With this research, we learned that no matter your goals, Keto5 doctors will optimize your program for your personal physiology and objectives - helping you hit targets faster and more effectively. 

*Our dietary ketone supplement has not been approved by the FDA nor do our products cure or treat any disease

In addition to weight loss, many patients may benefit from achieving durable increases of their ketosis levels when facing specific medical issues — such as diabetes, heart disease, autoimmune disorders, and even cancer — or to address a psychological challenge such as anxiety or depression.

We are all unique in our backgrounds and physical makeups. This type of tailored approach is the key to lasting metabolic results. We’re here to give the whole body treatment.

Ancient humanity had 90% fewer diseases than today

Our ancestors survived on fat stores (ketones) for days while hunting. And when they finally ate, it was mostly animal fat and protein. Human metabolism is still wired to work this way. Yet a carbohydrate-heavy diet has been foisted upon us for nearly 30 years, not to mention, billions in marketing by CPGs has driven average sugar consumption to 3 pounds per week (source).

Point blank: Living off of carbs and sugar now instead of fat is making us fat. So much so that 4 in 10 Americans are obese. Not just overweight, but obese. This obesity causes chronic inflammation everywhere in the body. 

(source)

So while obesity-induced inflammation is busy making us sick… along comes a viral pandemic. Recent data from the CDC demonstrates that obesity increases the risk of severe illness from COVID-19. People who are overweight (but not obese) may also be at increased risk. Obese people may have triple the risk of hospitalization due to a COVID-19 infection (source).

Promoting the therapeutic power of high ketosis levels to the American public will help solve many health problems associated with obesity. That’s where we come in.

We’re on a mission to improve quality of life for everyone

We’re seeing increasing popularity for the ketogenic diet (ancient man diet). 

And with that, Keto5 will help thousands of overweight or obese people lose weight under the direction of a physician (by far the most effective of all weight loss programs) and reduce levels of inflammation and vulnerability to a host of inflammation-related diseases. It takes the ketogenic diet to the next (and more powerful level).

KETO5 is optimizing human health and longevity through 360-degree ketogenic management. We are cultivating a network of physicians that Keto5 will specially train in all aspects of ketogenic management, including metabolic function, inflammation physiology and immunology, as well as ketogenic nutrition and diet design.

Upon joining the Keto5 program, you can choose to partner with one of these highly knowledgeable and compassionate experts, or continue working with your own personal physician as part of your supervised keto care regimen.

Our flagship product, XOGENIUS, is a ketone salt supplement that produces nutritional ketosis in minutes vs. hours or days in a ketogenic diet alone.

XOGENIUS safely yields 200% - 500% higher ketone levels in 1 dose. We believe this is upwards of 6X the potency of other formulas available today (source). And Keto5 has exclusive rights to sell to a clinical network from the patent holder of the main ingredient of XO Immune and XO Genius. 

XOGENIUS has helped patients achieve a median of 10 lbs. of weight loss and 81% reduced inflammation in just 30 days during proven clinical trials (source, source). Because of this efficacy, XOGENIUS even provides Nutritional Forgiveness. This means a flexible modern diet with some carbohydrates can be enjoyed while still maintaining adequate levels of ketosis.

Keto5 develops, manufactures, and will sell through a network of healthcare professionals its Keto5 products - all of which either contain exogenous ketone salts or related products to consume with the ketone salts-based products.

We'll sell Keto5  products initially through our clinical network that in turn sell to its patients. The company will also sell directly to consumers but only with the authorization of a network physician. They will be sold to health care professionals at a wholesale price that is more than double our cost of manufacturing. Our suite of exogenous salts products for mental sharpness, brain fog, esports, and other uses will be sold directly to consumers online with or without the authorization of a Keto5 clinical network healthcare provider. 

Ketogenic beverages alone are a $3B and growing category

But XOGENIUS doesn’t compete in the cluttered, low-margin, “snake oil” consumer market…  Instead, we leverage a physician-only distribution network — initially targeting medical weight loss.

Strategic hardware partnerships are in place to complete the program offering

Here’s a closer look at what we’ve been up to, and where we are headed:

• Spent 7 years doing research with actual patients
• Spent 6 years perfecting the products
• Designed all packaging
• New company logo and visual branding
• Completed website
• Hired agency to help build a clinical network
• Completed agreement to give Keto5 exclusive rights to sell products containing GoGHB, a key and indispensable ingredient in XOGENIUS and XOImmune in the clinical arena, giving us an enormous competitive advantage
• Keto5 has recently entered into a distribution agreement with a global manufacturer and distributor of food products for the weight loss industry. Between its France and North American operations, it generates annual revenues in excess of $60M. Under the terms of the agreement, they will be the exclusive distributor of Keto5 products for weight loss. This experienced and substantial manufacturer and distributor currently operates a clinical network of weight loss centers and physicians with more than 2,000 MDs in its network. It has also created an online portal and app that is managed by its team of registered dietitians. Under the terms of the contract that has an initial 5 year term with auto-renewals, they are is obligated to purchase sufficient quantities of Keto5 products to satisfy Keto5’s minimum purchase quantity requirements for GoBHB starting in January 2023. This contract alone guarantees minimum revenues for Keto5 of:

• Gross profits increase with volume but we are projecting that they will be in the 60% range as per the agreed wholesale prices with the experienced and substantial manufacturer and distributor, will be creating new flavors for XOGENIUS and XOIMMUNE as well as new products containing GoBHB including meal replacements (shakes), bars, chips, muffins, pancake mix, soups and gummies (please see risk factors in the Form C for additional information regarding projections).
• Have experienced core team consisting of a physician, engineer, and experienced entrepreneur and operator/attorney

Keto5 will help this experienced and substantial manufacturer and distributor increase its medical network for weight loss by co-marketing with them. Dr. Wool will be meeting with many large medical weight loss centers including IdealProtein, Metabolic, Ranier, Moxy, Lindora and others to persuade them of the benefits of products containing GoBHB for weight loss.

We believe that with a clinical network of only 1,000 health care professionals, apart from the experienced and substantial manufacturer and distributor’s existing network (out of a target range of 1,100,000 primary care and specialist physicians) could help us reach our goal  of becoming a $400 Million company. The value of the clinical network alone  will be extremely valuable.  

^{*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success.}

We believe Keto5 is poised to help more than 70% of America who are overweight live healthier, longer, and happier lives

Professional and consumer awareness of the powerful therapeutic benefits of high ketone levels in humans is in its infancy. Although the term “keto” has crept into the public vernacular over the past 5 years, the enormous range of benefits of ketosis is barely understood by the population at large. 

We are truly at the dawn of a new age where the power of ketones is about to be unlocked and unleashed. If this thesis is proven to be correct, then, given the company’s exclusive rights in the clinical network, we believe the potential for growth is enormous. 

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.